CatalystPit

SLDBSolid Biosciences Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $7.23 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$775.24M
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-06 · SMITH IAN F (Director) · OTHER
  • 2026-07-07 · SMITH IAN F (Director) · OTHER
  • 2026-04-02 · SMITH IAN F (Director) · OTHER
  • 2026-02-18 · Ganot Ilan (Director) · SELL
  • 2026-02-18 · Cumbo Alexander (President and CEO) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders164
Shares held123,756,815
Value$1.20B
Percent of shares outstanding115.42%
As of quarter end2026-06-30
RECENT NEWS
  • Solid Biosciences grants 8,150 RSUs to newly hired employee
  • Solid Biosciences: A Funded Challenge To Duchenne Gene Therapy's Limitations
  • RBC initiates Outperform rating on Solid Biosciences
  • Cantor Fitzgerald reiterates Overweight rating on Solid Biosciences stock
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Solid Biosciences Inc. (SLDB) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit